Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Gemini Therapeutics revenue
Gemini Therapeutics's revenue is $1.6 million.
What is Gemini Therapeutics's revenue?
- Gemini Therapeutics has 36 employees, and the revenue per employee ratio is $43,526.
- Gemini Therapeutics peak revenue was $1.6M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Gemini Therapeutics financing
Gemini Therapeutics received early financing of $2.0M on 2016-04-19.
| Series | Round size | Date |
|---|---|---|
| Seed | $2M | 04/2016 |
| Series A | $42.5M | 10/2017 |
| Post Ipo Equity | $95M | 02/2021 |
Gemini Therapeutics investors
| Investors | Security type |
|---|---|
| Lightstone Ventures | Seed |
| OrbiMed Advisors | Seed |
| Atlas Venture | Seed |
| Lightstone Ventures | Series A |
| OrbiMed Advisors | Series A |
| Atlas Venture | Series A |
| Suvretta Capital Management LLC | Post Ipo Equity |
| Acorn Bioventures | Post Ipo Equity |
| Cvf Capital Partners, Inc. | Post Ipo Equity |
| Fidelity Management & Research Co LLC | Post Ipo Equity |
| Dafna Capital Management | Post Ipo Equity |
| Atlas Venture | Post Ipo Equity |
| Lightstone Ventures | Post Ipo Equity |
| Wellington Management | Post Ipo Equity |
| Foresite Capital | Post Ipo Equity |
| Wu Capital | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| Boxer Capital | Post Ipo Equity |
| Alyeska Investment Group | Post Ipo Equity |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Gemini Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Gemini Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Gemini Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Gemini Therapeutics. The data presented on this page does not represent the view of Gemini Therapeutics and its employees or that of Zippia.
Gemini Therapeutics may also be known as or be related to Gemini Therapeutics, Gemini Therapeutics Inc and Gemini Therapeutics, Inc.